FREMONT, Calif., Jan. 6 /PRNewswire-FirstCall/ -- Protein Design Labs,
Inc. (PDL) (Nasdaq: PDLI) today announced that it will make available a live
webcast of its presentation at the 24th Annual JPMorgan Healthcare Conference
in San Francisco. The live webcast will begin at 8:30 a.m. Pacific time
(11:30 a.m. Eastern time) on January 11, 2006. The presentation will be
conducted by Mr. Mark McDade, Chief Executive Officer, and Dr. Steven Benner,
Senior Vice President and Chief Medical Officer. The live audio webcast of
the presentation will be available to all interested parties at PDL's website,
http://www.pdl.com, or may be directly accessed by the following link,
http://equityconferences.jpmorgan.com . A replay will be available via both
websites starting approximately 24 hours after the live presentation.
PDL is a biopharmaceutical company focused on the research, development
and commercialization of novel therapies for inflammation and autoimmune
diseases, acute cardiac conditions and cancer. PDL markets several
biopharmaceutical products in the United States through its hospital sales
force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the
development of humanized antibodies, PDL has licensed its patents to numerous
pharmaceutical and biotechnology companies, some of which are now paying
royalties on net sales of licensed products. Further information on PDL is
available at http://www.pdl.com.
NOTE: Protein Design Labs and the PDL logo are registered U.S. trademarks
of Protein Design Labs, Inc.
SOURCE Protein Design Labs, Inc.
 back to top
Related links:
http://www.pdl.com
CONTACT:
James R. Goff, Senior Director, Investor
Relations of Protein Design Labs, Inc., +1-510-574-1421, or
jgoff@pdl.com
|
